(Epilepsy Res[TA])
5,461 results
  • Beyond the classic ketogenic diet: A systematic review of alternative and adjunctive therapies for GLUT1 deficiency syndrome. [Review]
    Epilepsy Res. 2026 Sep 23; 228:107926. [Online ahead of print]Falsaperla R, Ben Amer S, Sortino VER
  • CONCLUSIONS: While CKD remains the reference standard for GLUT1-DS management, selected alternative and adjunctive therapies may offer clinically meaningful benefit in specific clinical contexts. The current evidence base, however, is limited. These findings support cautious and individualized use of alternative therapeutic strategies while highlighting the need for larger prospective studies and standardized outcome measures to better define their role in GLUT1-DS management.
  • Epilepsy-associated labor force exclusion in a multi-ethnic neurology cohort. [Journal Article]
    Epilepsy Res. 2026 Sep 16; 228:107920. [Online ahead of print]Heller S, McQueeny J, … Carrazana EER
  • CONCLUSIONS: In this single-center specialty-neurology cohort, epilepsy was associated with lower documented employment and higher recorded unemployment or disability than a contemporaneous comparator with other neurological conditions. These cross-sectional findings should be interpreted in the context of a clinically selected referral population and unmeasured neurological, functional, occupational, and socioeconomic factors.
  • Dissociating decision-making deficits in temporal and frontal lobe epilepsy using Bayesian methods. [Journal Article]
    Epilepsy Res. 2026 Sep 02; 228:107906. [Online ahead of print]Cairós-González M, Hidalgo B, Verche EER
  • CONCLUSIONS: Focal epilepsy impacts decision-making efficiency in a manner contingent upon seizure focus. The observed distinctions between temporal groups tentatively suggest potential avenues for future longitudinal research into tailored neuropsychological interventions. These findings highlight the utility of Bayesian frameworks in providing a nuanced, probabilistic characterization of cognitive deficits in small sample sizes.
  • Risk factors for adverse maternal‑neonatal outcomes in pregnant women with epilepsy and the impact of different anti-seizure medications exposures on neonatal birth weight. [Journal Article]
    Epilepsy Res. 2026 Aug 20; 227:107899. [Online ahead of print]Fang C, Yang H, Yang YER
  • CONCLUSIONS: Uncontrolled epilepsy before and during pregnancy, polytherapy, focal epilepsy, and gestational hypertension are independent risk factors for adverse maternal‑neonatal outcomes in pregnant women with epilepsy. Different ASMs have differential effects on neonatal birth weight; valproate and polytherapy are associated with significantly lower birth weight. Physicians should counsel women with epilepsy that achieving at least six months of seizure freedom before conception is associated with improved maternal-neonatal outcomes. Lamotrigine or levetiracetam monotherapy should be prioritized whenever possible, and close monitoring should be maintained throughout pregnancy.
  • Impact of pediatric epilepsy surgery on healthcare resource use. [Journal Article]
    Epilepsy Res. 2026 Aug 19; 227:107901. [Online ahead of print]Aguirre AS, Pijs DA, Sánchez Fernández IER
  • CONCLUSIONS: Among pediatric patients with drug-resistant epilepsy, healthcare resource use substantially decreases after epilepsy surgery, especially when the patient does not require subsequent epilepsy surgeries. Results were similar for all types of insurance, for all races, and for all ethnicities.